For research use only
| Cat No. | ABC-SC0011T |
| Product Type | Human iPSCs |
| Cell Type | Induced Pluripotent Stem Cell |
| Species | Human |
| Growth Conditions | 37 ℃, 5% CO2 |
| Source Organ | Adipose |
| Disease | Diabetes Type II |
| Storage | Liquid Nitrogen |
HighQC™ Human IPS Cell (Episomal/Diabetes Type II/Adipose) supports disease modeling, drug screening and regenerative research for PD and type II diabetes.
HighQC™ Human iPSCs (Episomal/ Diabetes Type II/ Adipose) are induced pluripotent stem cells derived from adipose-derived somatic cells of a Type 2 Diabetes (T2D) donor. The cells align with the classic characteristics of induced pluripotent stem cells (iPSCs). Reprogramming was performed using episomal vectors. These resulting cells exhibit key hallmarks of pluripotency, including compact colony morphology and high expression of markers such as OCT4, NANOG, and SOX2. These cells maintain genomic stability and the potential for trilineage differentiation, making them highly relevant for diabetes and metabolic disorder research. The cells undergo rigorous screening and isolation procedures, and are rigorously tested to ensure they are free of contamination from HIV-1, HBV, HCV, syphilis, mycoplasma, fungi, yeast, and bacteria.
| Product Code | HighQC™ Human IPS Cell (Episomal/ Diabetes Type II/ Adipose), Human iPSC-Epi-T2D-Adipose, hIPSC-Epi-T2D-Adipose, Human Adipose Derived Episomal iPSC Type II Diabetes |
| Species | Human |
| Cat.No | ABC-SC0011T |
| Product Category | Stem Cells |
| Size/Quantity | 1 vial |
| Cell Type | Induced Pluripotent Stem Cell |
| Growth Mode | Adherent |
| Shipping Info | Dry Ice |
| Growth Conditions | 37 ℃, 5% CO2 |
| Source Organ | Adipose |
| Disease | Diabetes Type II |
| Storage | Liquid Nitrogen |
| Product Type | Human iPSCs |
HighQC™ Human iPSCs (Episomal/ Diabetes Type II/ Adipose) serve as a physiologically relevant in vitro platform for modeling Type 2 Diabetes Mellitus (T2DM) pathophysiology and metabolic dysfunction. These cells can be directed to differentiate into adipocytes, enabling the study of adipocyte dysfunction mechanisms, insulin resistance, and lipid metabolism. They are particularly useful in drug discovery, allowing high-throughput screening of compounds targeting adipocyte function and metabolic homeostasis in T2DM and obesity.
When you publish your research, please cite our product as "AcceGen Biotech Cat.# XXX-0000". In return, we’ll give you a $200 coupon. Simply click here and submit your paper’s PubMed ID (PMID).